Biography and Research Information
OverviewAI-generated summary
Brett Daughdrill's research centers on the cardiovascular impacts of advanced medical therapies, particularly CAR-T cell therapy. His work investigates the prediction and identification of adverse cardiovascular events following CAR-T treatment, with a focus on cytokine release syndrome as a trigger for cancer therapy-related cardiac dysfunction. Daughdrill also studies echocardiographic indices to assess heart failure outcomes in individuals with sickle cell disease. His recent publications explore the surveillance of cardiotoxicity and prognostication of cardiovascular events in these specific patient populations. Daughdrill collaborates with researchers at the University of Arkansas for Medical Sciences, including J. Curran Henson and Grant M. Spears, and with Adetayo Odueke at the University of Arkansas at Fayetteville.
Metrics
- Publications: 6
Selected Publications
-
Bridging the Coverage Gap: State Medicaid Limitations for Cardiac Rehabilitation Programs and the Risk to Disadvantaged Communities (2026)
-
26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS (2026)
-
PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)
-
ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE (2025)
Collaboration Network
Top Collaborators
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- Abstract 4358782: Redefining Cardiotoxicity Surveillance in Targeted Immunotherapy: Cytokine Release Syndrome as a High-Yield Trigger for Detecting Cancer Therapy-Related Cardiac Dysfunction After CAR-T Therapy
Similar Researchers
Based on overlapping research topics